![Han Xiong Li](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Net worth: 1 120 M $ as of 31/08/2026
Han Xiong Li is the founder of Apichope Pharmaceutical Group Co., Ltd., founded in 2002, holding the titles of Chairman & General Manager.
Dr. Li currently holds the position of Chairman at Guangdong Zerui Pharmaceutical Co. Ltd. Dr. Li obtained a doctorate from the University of Geneva and an MBA from China Europe International Business School in 2011.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 30/09/2025 | 189,810,000 ( 44.89% ) | 1 020 M $ | 31/08/2026 | |
| 30/09/2025 | 18,630,000 ( 51.07% ) | 100 M $ | 31/08/2026 |
| Companies | Position | Start |
|---|---|---|
| APICHOPE PHARMACEUTICAL GROUP CO., LTD. | Chief Executive Officer | 11/11/2015 |
Guangdong Zerui Pharmaceutical Co. Ltd.
 Guangdong Zerui Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Chairman | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 4 |
|---|---|
University of Geneva
 University of Geneva Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
China Europe International Business School
 China Europe International Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ApicHope Pharmaceutical Co., Ltd.
 ApicHope Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals | Health Technology |
Guangdong Zerui Pharmaceutical Co. Ltd.
Guangdong Zerui Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
